Annual CFF
$38.61 M
+$17.41 M+82.12%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual cash flow from financing activities is $38.61 million, with the most recent change of +$17.41 million (+82.12%) on December 31, 2023.
- During the last 3 years, ELTX annual CFF has risen by +$13.55 million (+54.07%).
- ELTX annual CFF is now at all-time high.
Performance
ELTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$30.75 M
+$30.44 M+9632.28%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly cash flow from financing activities is $30.75 million, with the most recent change of +$30.44 million (+9632.28%) on September 30, 2024.
- Over the past year, ELTX quarterly CFF has increased by +$30.69 million (+51156.67%).
- ELTX quarterly CFF is now at all-time high.
Performance
ELTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$49.09 M
+$30.69 M+166.81%
September 30, 2024
Summary
- As of February 8, 2025, ELTX TTM cash flow from financing activities is $49.09 million, with the most recent change of +$30.69 million (+166.81%) on September 30, 2024.
- Over the past year, ELTX TTM CFF has increased by +$17.48 million (+55.30%).
- ELTX TTM CFF is now at all-time high.
Performance
ELTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ELTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +82.1% | +10000.0% | +55.3% |
| 3 y3 years | +54.1% | +206.3% | +389.0% |
| 5 y5 years | +513.5% | +206.3% | +389.0% |
ELTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.1% | at high | >+9999.0% | at high | +859.7% |
| 5 y | 5-year | at high | +513.5% | at high | >+9999.0% | at high | +859.7% |
| alltime | all time | at high | +513.5% | at high | >+9999.0% | at high | +859.7% |
Elicio Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $30.75 M(+9632.3%) | $49.09 M(+166.8%) |
| Jun 2024 | - | $316.00 K(-97.1%) | $18.40 M(-53.5%) |
| Mar 2024 | - | $11.02 M(+57.5%) | $39.60 M(+2.5%) |
| Dec 2023 | $38.61 M | $7.00 M(>+9900.0%) | $38.61 M(+22.1%) |
| Sep 2023 | - | $60.00 K(-99.7%) | $31.61 M(+0.2%) |
| Jun 2023 | - | $21.51 M(+114.3%) | $31.55 M(+214.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $10.04 M(+96.3%) | $10.04 M(+96.3%) |
| Dec 2022 | $21.20 M(+9.3%) | - | - |
| Dec 2021 | $19.39 M(-22.6%) | - | - |
| Mar 2021 | - | $5.12 M(-31.9%) | $5.12 M(-31.9%) |
| Dec 2020 | $25.06 M(+298.2%) | - | - |
| Mar 2020 | - | $7.51 M | $7.51 M |
| Dec 2019 | $6.29 M | - | - |
FAQ
- What is Elicio Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Elicio Therapeutics?
- What is Elicio Therapeutics annual CFF year-on-year change?
- What is Elicio Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly CFF year-on-year change?
- What is Elicio Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Elicio Therapeutics?
- What is Elicio Therapeutics TTM CFF year-on-year change?
What is Elicio Therapeutics annual cash flow from financing activities?
The current annual CFF of ELTX is $38.61 M
What is the all time high annual CFF for Elicio Therapeutics?
Elicio Therapeutics all-time high annual cash flow from financing activities is $38.61 M
What is Elicio Therapeutics annual CFF year-on-year change?
Over the past year, ELTX annual cash flow from financing activities has changed by +$17.41 M (+82.12%)
What is Elicio Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ELTX is $30.75 M
What is the all time high quarterly CFF for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly cash flow from financing activities is $30.75 M
What is Elicio Therapeutics quarterly CFF year-on-year change?
Over the past year, ELTX quarterly cash flow from financing activities has changed by +$30.69 M (+51156.67%)
What is Elicio Therapeutics TTM cash flow from financing activities?
The current TTM CFF of ELTX is $49.09 M
What is the all time high TTM CFF for Elicio Therapeutics?
Elicio Therapeutics all-time high TTM cash flow from financing activities is $49.09 M
What is Elicio Therapeutics TTM CFF year-on-year change?
Over the past year, ELTX TTM cash flow from financing activities has changed by +$17.48 M (+55.30%)